Please use this identifier to cite or link to this item: http://hdl.handle.net/2381/41046
Title: Effect of insulin glargine on recreational physical activity and TV viewing: Analysis of the randomised ORIGIN trial.
Authors: Yates, Tom
Davies, Melanie J.
Jung, Hyejung
Bosch, Jackie
Spinas, Giatgen A.
Sreenan, Seamus
Commerford, Patrick
Gerstein, Hertzel C.
ORGIN investigators
First Published: 31-Jul-2017
Publisher: Elsevier for International Diabetes Federation
Citation: Diabetes Research and Clinical Practice, 2017, 132, pp. 137-143
Abstract: AIMS: To quantify whether insulin therapy, and concomitant weight gain, affects recreational physical activity and TV viewing time using data from the Outcomes Reduction with an Initial Glargine Intervention (ORIGIN) trial. METHODS: 12,537 insulin-naïve individuals with dysglycaemia were randomised to receive either basal insulin glargine or standard care and followed for a median of 6.2years. Complete recreational physical activity and TV viewing time questionnaires across baseline, 2year follow-up and study end were available for 8954 participants. Differences between groups at follow-up were assessed by analysis of covariance. RESULTS: At follow-up, there was no difference in physical activity or TV viewing time between those taking insulin glargine and those receiving standard care, despite body weight increasing by 1.66 (7.56) kg in the insulin glargine group and reducing by -0.65 (7.90) kg in the standard care group (P<0.001). The dose of insulin glargine was not associated with changes in physical activity. CONCLUSIONS: Despite modest weight gain, insulin glargine did not adversely impact recreational physical activity levels within an international cohort with dysglyaemia. ORIGIN ClinicalTrials.gov number: NCT00069784.
DOI Link: 10.1016/j.diabres.2017.07.035
ISSN: 0168-8227
eISSN: 1872-8227
Links: https://www.sciencedirect.com/science/article/pii/S0168822717305685?via%3Dihub
http://hdl.handle.net/2381/41046
Version: Post-print
Status: Peer-reviewed
Type: Journal Article
Rights: Copyright © 2017, Elsevier for International Diabetes Federation. Deposited with reference to the publisher’s open access archiving policy.
Description: The file associated with this record is under embargo until 12 months after publication, in accordance with the publisher's self-archiving policy. The full text may be available through the publisher links provided above.
Appears in Collections:Published Articles, Dept. of Medical and Social Care Education

Files in This Item:
File Description SizeFormat 
ORIGIN 2017 DRCP R1 clean.pdfPost-review (final submitted author manuscript)378.98 kBAdobe PDFView/Open


Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.